Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks

Arch Ophthalmol. 2007 Oct;125(10):1422-3. doi: 10.1001/archopht.125.10.1422.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Angioid Streaks / complications*
  • Angioid Streaks / diagnosis
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Female
  • Fluorescein Angiography
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Pseudoxanthoma Elasticum / complications
  • Pseudoxanthoma Elasticum / diagnosis
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab